Related Experiment Video
Updated: May 5, 2026

Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
Published on: June 30, 2016
A Novel Small Molecule Accelerates Early Persister Regrowth and Potentiates Antibiotic Killing via MdtL-DcrB
Garin Park1, Hyein Kim2, Sooyeon Song1,2
1Agriculture Convergence Technology, Jeonbuk National University, Jeonju-Si, Jellabuk-Do, South Korea.
Abstract:
Persister cells survive antibiotic exposure through transient tolerance, often leading to infection relapse. Because antibiotic susceptibility is restored when persisters resume growth, we sought to identify a chemical modulator that advances early regrowth and to define the pathway underlying its activity. A screen of 7040 compounds led to the discovery of bymBDZ, which shortens the lag phase and promotes early regrowth in persister-derived Escherichia coli. bymBDZ significantly enhanced antibiotic killing during early treatment windows when survivors are typically retained, and this activity extended to enterohemorrhagic E. coli O157:H7 and multiple antibiotic classes. Genetic and functional analyses showed that bymBDZ activity required the membrane transporter MdtL and the envelope factor DcrB. bymBDZ induced dcrB expression and remodelled envelope-associated transport, resulting in increased intracellular exposure to small molecules during early regrowth, as indicated by elevated dye accumulation. Consistent with this remodelling, bymBDZ promoted faster growth resumption and reinforced antibiotic killing during early regrowth. Collectively, these findings identify bymBDZ as a chemical probe that modulates persister regrowth through MdtL-DcrB-dependent envelope transport remodelling and suggest a strategy to sensitize tolerant bacteria to antibiotics.
Insights
A new compound, bymBDZ, helps persister cells (bacteria that survive antibiotics) regrow faster. This makes them more susceptible to antibiotics, offering a strategy to combat persistent infections.
Area of Science:
- Microbiology
- Pharmacology
- Bacterial Physiology
Background:
- Persister cells are dormant bacteria that survive antibiotic treatment, leading to recurrent infections.
- Resuming growth restores antibiotic susceptibility in persister cells, but the mechanisms controlling this transition are not fully understood.
Purpose of the Study:
- To identify chemical modulators that accelerate persister cell regrowth.
- To elucidate the molecular pathway responsible for bymBDZ-mediated regrowth modulation.
Main Methods:
- High-throughput screening of 7040 compounds to identify regrowth modulators.
- Genetic and functional analyses to determine the mechanism of action of bymBDZ.
- Assays for antibiotic susceptibility, dye accumulation, and gene expression.
Main Results:
- The compound bymBDZ was identified, significantly shortening the lag phase and promoting early regrowth in persister Escherichia coli.
- bymBDZ enhanced antibiotic killing of persisters and extended to E. coli O157:H7 and multiple antibiotic classes.
- bymBDZ activity required the membrane transporter MdtL and envelope factor DcrB, inducing dcrB expression and remodelling envelope transport.
Conclusions:
- bymBDZ acts as a chemical probe that modulates persister regrowth via MdtL-DcrB-dependent envelope transport remodelling.
- This mechanism increases intracellular exposure to small molecules during early regrowth, sensitizing bacteria to antibiotics.
- bymBDZ represents a potential strategy to enhance antibiotic efficacy against persistent bacterial infections.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Bacterial DNA Synthesis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antibiotic Selection
Clinical Significance of Antibiotic Resistance
Negative Regulator Molecules

